Literature DB >> 23429553

Prevalence of respiratory syncytial virus-associated lower respiratory infection and apnea in infants presenting to the emergency department.

Mary Allen Staat1, Kelly Henrickson, Hanaa Elhefni, Jessie Groothuis, Doris Makari.   

Abstract

The prevalence of respiratory syncytial virus in children presenting to US emergency departments with lower respiratory tract infection or apnea (N = 4172) was evaluated outside the traditional respiratory syncytial virus season (September to October and April to May) relative to January to February. The Mid-Atlantic and Southeast demonstrated positivity rates in September to October comparable with rates observed during January to February.

Entities:  

Mesh:

Year:  2013        PMID: 23429553     DOI: 10.1097/INF.0b013e31828df3e3

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  4 in total

1.  Changes in Critical Bronchiolitis After COVID-19 Lockdown.

Authors:  Jose Cardenas; Charlene Pringle; Stephanie L Filipp; Matthew J Gurka; Kathleen A Ryan; K Leslie Avery
Journal:  Cureus       Date:  2022-05-17

2.  Respiratory syncytial virus surveillance in the United States, 2007-2012: results from a national surveillance system.

Authors:  Catherine Balderston McGuiness; Marnie L Boron; Brett Saunders; Laurel Edelman; Veena R Kumar; Karma M Rabon-Stith
Journal:  Pediatr Infect Dis J       Date:  2014-06       Impact factor: 2.129

3.  The Underrecognized Burden of Respiratory Syncytial Virus Among Infants Presenting to US Emergency Departments.

Authors:  Doris Makari; Mary Allen Staat; Kelly J Henrickson; Xionghua Wu; Christopher S Ambrose
Journal:  Clin Pediatr (Phila)       Date:  2014-08-06       Impact factor: 1.168

4.  Caffeine for the Treatment of Apnea in Bronchiolitis: A Randomized Trial.

Authors:  Khalid Alansari; Fatihi Hassan Toaimah; Hany Khalafalla; Lamiaa Awny El Tatawy; Bruce L Davidson; Wessam Ahmed
Journal:  J Pediatr       Date:  2016-05-14       Impact factor: 4.406

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.